Nextgen Biomed Ltd (NXGN.TA)

TLV Healthcare Medical - Instruments & Supplies

Nextgen Biomed Ltd operates in the Medical - Instruments & Supplies industry of the Healthcare sector, headquartered in Tel Aviv, IL. The stock last traded at $47.00, down 4.08% on the session, giving a market capitalisation of $5.1M. Its beta of 0.70 implies it has historically moved less than the broad market.

Nextgen Biomed Ltd focuses on developing external dermatological treatments for psoriasis. The company, which was established in 1990, originally operated under the name Sela Group.Com Ltd. before rebranding as Nextgen Biomed Ltd in February 2010. Its operations are headquartered in Tel Aviv, Israel.